Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

EPA’s pleiotropic mechanisms of action: a narrative review
John Nelson, Matthew J. Budoff, Omar R Wani, et al.
Postgraduate Medicine (2021), pp. 1-14
Open Access | Times Cited: 28

Showing 1-25 of 28 citing articles:

Pickering emulsions stabilized by pea protein isolate-chitosan nanoparticles: fabrication, characterization and delivery EPA for digestion in vitro and in vivo
Yuan Ji, Chenlu Han, Enchao Liu, et al.
Food Chemistry (2022) Vol. 378, pp. 132090-132090
Closed Access | Times Cited: 102
Omega-3 world map: 2024 update
Jan Philipp Schuchardt, Philine Beinhorn, Xue Feng Hu, et al.
Progress in Lipid Research (2024) Vol. 95, pp. 101286-101286
Open Access | Times Cited: 26
Reducing residual cardiovascular risk in Europe: Therapeutic implications of European medicines agency approval of icosapent ethyl/eicosapentaenoic acid
M. John Chapman, José Luís Zamorano, Klaus G. Parhofer
Pharmacology & Therapeutics (2022) Vol. 237, pp. 108172-108172
Open Access | Times Cited: 42
Mechanisms Underlying Antiarrhythmic Properties of Cardioprotective Agents Impacting Inflammation and Oxidative Stress
Katarína Andelová, Barbara Szeiffová Bačová, Matúš Sýkora, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 3, pp. 1416-1416
Open Access | Times Cited: 33
Triglycerides revisited: is hypertriglyceridaemia a necessary therapeutic target in cardiovascular disease?
Heinz Drexel, Juan Tamargo, Juan Carlos Kaski, et al.
European Heart Journal - Cardiovascular Pharmacotherapy (2023) Vol. 9, Iss. 6, pp. 570-582
Open Access | Times Cited: 16
Use of Lipid-Lowering Drugs After Intracerebral Hemorrhage
Ashkan Shoamanesh, Magdy Selim
Stroke (2022) Vol. 53, Iss. 7, pp. 2161-2170
Open Access | Times Cited: 19
Fenofibrate’s impact on cardiovascular risk in patients with diabetes: a nationwide propensity-score matched cohort study
Sangmo Hong, Kyung‐Soo Kim, Kyungdo Han, et al.
Cardiovascular Diabetology (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 3
Can supplementation with antioxidants improve cognitive functions in patients with multiple sclerosis? A literature review
Ali Rezaei, Majid Hamidi, Homa Seyedmirzaei, et al.
Annals of Medicine and Surgery (2025) Vol. 87, Iss. 5, pp. 2736-2748
Open Access
Icosapent ethyl for reduction of persistent cardiovascular risk: a critical review of major medical society guidelines and statements
Michael Miller, Lâle Tokgözoğlu, Klaus G. Parhofer, et al.
Expert Review of Cardiovascular Therapy (2022) Vol. 20, Iss. 8, pp. 609-625
Open Access | Times Cited: 16
Higher docosahexaenoic acid levels lower the protective impact of eicosapentaenoic acid on long-term major cardiovascular events
Viet T. Le, Stacey Knight, Jeramie D. Watrous, et al.
Frontiers in Cardiovascular Medicine (2023) Vol. 10
Open Access | Times Cited: 9
Omega‐3 fatty acids for the prevention of atherosclerotic cardiovascular disease
Arden R. Barry, Dave L. Dixon
Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy (2021) Vol. 41, Iss. 12, pp. 1056-1065
Closed Access | Times Cited: 19
Differentiating EPA from EPA/DHA in cardiovascular risk reduction
Peter P. Tóth, M. John Chapman, Klaus G. Parhofer, et al.
American Heart Journal Plus Cardiology Research and Practice (2022) Vol. 17, pp. 100148-100148
Open Access | Times Cited: 14
Plasma fatty acid profiles: Relationships with sex, age, and state-reported heart disease mortality rates in the United States
Margaret R. Diffenderfer, Nandani Rajapakse, Ericka Pham, et al.
Journal of clinical lipidology (2022) Vol. 16, Iss. 2, pp. 184-197
Open Access | Times Cited: 13
Maternal AA/EPA Ratio and Triglycerides as Potential Biomarkers of Patients at Major Risk for Pharmacological Therapy in Gestational Diabetes
Chiara Maria Soldavini, Gabriele Piuri, Gabriele Rossi, et al.
Nutrients (2022) Vol. 14, Iss. 12, pp. 2502-2502
Open Access | Times Cited: 10
Enhanced Production of EPA-Derived Anti-Inflammatory Metabolites after Oral Administration of a Novel Self-Emulsifying Highly Purified EPA Ethyl Ester Formulation (MND-2119)
Toru Miyoshi, Satoko Naoe, Hiroyuki Wakabayashi, et al.
Journal of Atherosclerosis and Thrombosis (2023) Vol. 30, Iss. 12, pp. 1927-1949
Open Access | Times Cited: 5
Statin therapy upregulates arachidonic acid status via enhanced endogenous synthesis in patients with plaque psoriasis
Michael Garshick, Robert Block, Kamelia Drenkova, et al.
Prostaglandins Leukotrienes and Essential Fatty Acids (2022) Vol. 180, pp. 102428-102428
Open Access | Times Cited: 8
Effect of statin add-on therapy on cardiovascular mortality
John Nelson, Viet T. Le, Jeffrey L. Anderson, et al.
Frontiers in Cardiovascular Medicine (2024) Vol. 11
Open Access | Times Cited: 1
Intermediate and long-term residual cardiovascular risk in patients with established cardiovascular disease treated with statins
Krishnaswami Vijayaraghavan, Seth J. Baum, Nihar R. Desai, et al.
Frontiers in Cardiovascular Medicine (2024) Vol. 10
Open Access | Times Cited: 1
The Impact of Omega-3 Supplements on Non-Surgical Periodontal Therapy: A Systematic Review
Luísa Martins Miller, Flávia Benetti Piccinin, U. van der Velden, et al.
Nutrients (2022) Vol. 14, Iss. 9, pp. 1838-1838
Open Access | Times Cited: 6
The Anti-Aggregative Potential of Resolvin E1 on Human Platelets
Patrycja Szymańska, Bogusława Luzak, Katarzyna Miłowska, et al.
Molecules (2023) Vol. 28, Iss. 14, pp. 5323-5323
Open Access | Times Cited: 3
Global eligibility and cost effectiveness of icosapent ethyl in primary and secondary cardiovascular prevention
Peter P. Tóth, Jean Ferrières, M Waters, et al.
Frontiers in Cardiovascular Medicine (2023) Vol. 10
Open Access | Times Cited: 3
Ultrasensitive dose-response for asbestos cancer risk implied by new inflammation-mutation model
Kenneth T. Bogen
Environmental Research (2023) Vol. 230, pp. 115047-115047
Open Access | Times Cited: 2
Effects of Walnut-Rich Diet on Cation-Handling Proteins in the Heart of Healthy and Metabolically Compromised Male Rats
Snežana Tepavčević, Snježana Romić, Manja Zec, et al.
Journal of Medicinal Food (2023) Vol. 26, Iss. 11, pp. 849-857
Closed Access | Times Cited: 2
Tibetan Butter and Indian Ghee: A Review on Their Production and Adulteration
Fumin Chi, Zhankun Tan, Qianwei Wang, et al.
Agriculture (2024) Vol. 14, Iss. 9, pp. 1533-1533
Open Access
Differential Effect of Omega-3 Fatty Acids on Platelet Inhibition by Antiplatelet Drugs In Vitro
Ioannis K. Koutsaliaris, Despoina Pantazi, Aikaterini N. Tsouka, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 18, pp. 10136-10136
Open Access
Page 1 - Next Page

Scroll to top